Atlas Trials

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

Clinical trial NCT04156191 · COMPLETED

Trial details

NCT number
NCT04156191
Sponsor
Arcutis Biotherapeutics, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Atopic Dermatitis (Eczema)
Start date
2019-12-23
Primary completion
2023-05-02
Enrollment
101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.